Filariases

Manson's Tropical Diseases, Twenty-second Edition

Volumn , Issue , 2008, Pages 1477-1513

  Simonsen, Paul E ^a  

^a DANISH BILHARZIASIS LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85158990299     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4470-3.50088-4     Document Type: Chapter

References (187)

1. World Health Organization (1992) Lymphatic filariasis: the disease and its control. Fifth report of the WHO expert committee on filariasis. WHO Tech Rep Ser 821.
2. JN Demarquay (1863) Note sur une tumeur des bourses contenant un liquide laiteux (galactocèle de Vidal) et referment des petits êtres vermiformes que l'on peut considérer comme des helminthes hematoides à l'état d'embryon. Gaz Méd Paris 18 665-667.
3. OE Wucherer (1868) Noticia preliminar sobre vermes de una especie ainda não descripta, encontrados na urina de doentes de hematuria intertropical no Brazil. Gaz Med Bahia 3 97-99.
4. TR Lewis (1872) On a haematozoon inhabiting human blood, its relation to chyluria and other diseases. Lancet i 889-890.
5. TS Cobbold (1877) Discovery of the adult representative of microscopic filariae. Lancet ii 70-71.
6. IA McGregor (1995) The Third Manson Oration. Patrick Manson 1844-1922: the birth of the science of tropical medicine. Trans R Soc Trop Med Hyg 89 1-8.
7. DI Grove (1990) A History of Human Helminthology London: CAB International
8. E Michael and DAP Bundy (1997) Global mapping of lymphatic filariasis. Parasitol Today 13 472-476.
9. PE Simonsen, L Niemann and DW Meyrowitsch (1997) Wuchereria bancrofti in Tanzania: microfilarial periodicity and effect of blood sampling time on microfilarial intensities. Trop Med Int Hlth 2 153-158.
10. PE Simonsen, DW Meyroitsch, WG Jaoko, et al. (2002) Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa. Am J Trop Med Hyg 66 550-559.
11. G Dreyer, D Addiss, J Roberts, et al. (2002) Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 96 157-161.
12. DO Freedman, PJA Filho, S Besh, et al. (1994) Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis 70 927-933.
13. P Bernhard, RW Makunde, P Magnussen, et al. (2000) Genital manifestations and reproductive health in female residents of a Wuchereria bancrofti-endemic area in Tanzania. Trans R Soc Trop Med Hyg 94 409-412.
14. SK Dunyo, FK Nkrumah, CK Ahorlu, et al. (1998) Exfoliative skin manifestations in acute lymphatic filariasis. Trans R Soc Trop Med Hyg 92 539-540.
15. DB Gasarasi, ZG Premji, PGM Mujinja, et al. (2000) Acute adenolymphangitis due to bancroftian filariasis in Rufiji district, south east Tanzania. Acta Trop 75 19-28.
16. G Dreyer, Z Medeiros, MJ Netto, et al. (1999) Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg 93 413-417.
17. JE McMahon, SA Magayuka, N Kolstrup, et al. (1981) Studies on the transmission and prevalence of bancroftian filariasis in four coastal villages of Tanzania. Ann Trop Med Parasitol 75 415-431.
18. DW Meyrowitsch, PE Simonsen and WH Makunde (1995) Bancroftian filariasis: analysis of infection and disease in five endemic communities of north-eastern Tanzania. Ann Trop Med Parasitol 89 653-663.
19. SK Dunyo, CK Ahorlu and PE Simonsen (1997) Scarification as a risk factor for rapid progression of filarial elephantiasis. Trans R Soc Trop Med Hyg 91 446.
20. G Dreyer, D Addiss, P Dreyer, et al. (2002) Basic Lymphoedema Management, Treatment and Prevention of Problems Associated with Lymphatic Filariasis Middlesex: Hollis Publishing
21. EA Ottesen and TB Nutman (1992) Tropical pulmonary eosinophilia. Annu Rev Med 43 417-424.
22. G Dreyer, P Dreyer and WF Piessens (1999) Extralymphatic disease due to bancroftian filariasis. Braz J Med Biol Res 32 1467-1472.
23. T Supali, H Wibowo, P Rückert, et al. (2002) High prevalence of Brugia timori infection in the highland of Alor Island, Indonesia. Am J Trop Med Hyg 66 560-565.
24. P Magnussen, W Makunde, PE Simonsen, et al. (1995) Chronic pulmonary disorders, including tropical pulmonary eosinophilia, in villages with endemic lymphatic filariasis in Tanga region and in Tanga town, Tanzania. Trans R Soc Trop Med Hyg 89 406-409.
25. JW Kazura, M Bockarie, N Alexander, et al. (1997) Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. J Infect Dis 176 242-246.
26. AW Onapa, PE Simonsen and EM Pedersen (2001) Non-filarial elephantiasis in the Mt. Elgon area (Kapchorwa District) of Uganda. Acta Tropica 78 171-176.
27. JE McMahon, TFC Marshall, JP Vaughan, et al. (1979) Bancroftian filariasis: a comparison of microfilariae counting techniques using counting chamber, standard slide and membrane (nuclepore) filtration. Ann Trop Med Parasitol 73 457-464.
28. JE McMahon, TFC Marshall, JP Vaughan, et al. (1979) Tanzania filariasis project: a provocative day test with diethylcarbamazine for the detection of microfilariae of nocturnally periodic Wuchereria bancrofti in the blood. Bull World Health Organ 57 759-765.
29. PE Simonsen, DW Meyrowitsch and WH Makunde (1997) Bancroftian filariasis: long-term effect of the DEC provocative day test on microfilaraemia. Trans R Soc Trop Med Hyg 91 290-293.
30. SK Dunyo, FK Nkrumah and PE Simonsen (1999) A study on the provocative day test effect of ivermectin and albendazole on nocturnal periodic Wuchereria bancrofti microfilaraemia. Trans R Soc Trop Med Hyg 93 608-610.
31. M Jamail, K Andrew, D Junaidi, et al. (2005) Field validation of sensitivity and specificity of rapid test for detection of Brugia malayi infection. Trop Med Int Hlth 10 99-104.
32. PJ Lammie, G Weil, R Noordin, et al. (2004) Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J 3 9.
33. MV Weerasooriya, M Itoh, MZ Islam, et al. (2003) Prevalence and levels of filaria-specific urinary IgG4 among children less than five years of age and the association of antibody positivity between children and their mothers. Am J Trop Med Hyg 68 465-468.
34. PE Simonsen and SK Dunyo (1999) Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens. Trans R Soc Trop Med Hyg 93 278-282.
35. M Walther and R Muller (2003) Diagnosis of human filariasis (except onchocerciasis). Adv Parasitol 53 149-193.
36. SA Williams, SJ Laney, LA Bierwert, et al. (2002) Development and standardization of a rapid, PCR based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of bancroftian filariasis. Ann Trop Med Parasitol 96 S41-S46.
37. P Fischer, D Boakye and J Hamburger (2003) Polymerase chain reaction-based detection of lymphatic filariasis. Med Microbiol Immunol 192 3-7.
38. G Dreyer, A Santos, J Norões, et al. (1998) Ultrasonographic detection of living adult Wuchereria bancrofti using a 3.5-MHz transducer. Am J Trop Med Hyg 59 399-403.
39. S Mand, Y Marfo-Debrekyei, M Dittrich, et al. (2003) Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis. Filaria J 2 3.
40. S Mand, A Debrah, L Batsa, et al. (2004) Reliable and frequent detection of adult Wuchereria bancrofti in Ghanaian women by ultrasonography. Trop Med Int Hlth 9 1111-1114.
41. S Mand, T Supali, J Djuardi, et al. (2006) Detection of adult Brugia malayi filariae by ultrasonography in humans in India and Indonesia. Trop Med Int Hlth 11 1375-1381.
42. RM Maizels, E Sartono, A Kurniawan, et al. (1995) T-cell activation and the balance of antibody isotypes in human lymphatic filariasis. Parasitol Today 11 50-56.
43. E Michael, BT Grenfell and DAP Bundy (1994) The association between microfilaraemia and disease in lymphatic filariasis. Proc R Soc Lond B Biol Sci 256 33-40.
44. DO Freedman (1998) Immune dynamics in the pathogenesis of human lymphatic filariasis. Parasitol Today 14 229-233.
45. L Nicolas, S Langy, C Plichart, et al. (1999) Filarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status. Parasite Immunol 21 73-80.
46. WG Jaoko, PE Simonsen, DW Meyrowitsch, et al. (2006) Filarial-specific antibody response in East African bancroftian filariasis: effects of host infection, clinical disease, and filarial endemicity. Am J Trop Med Hyg 75 97-107.
47. G Dreyer, J Norões, J Figueredo-Silva, et al. (2000) Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 16 544-548.
48. MJ Taylor (2003) Wolbachia in the inflammatory pathogenesis of human filariasis. Ann NY Acad Sci 990 444-449.
49. WL Olszewski, S Jamal, G Manokaran, et al. (1999) Bacteriological studies of blood, tissue fluid, lymph and lymph nodes in patients with acute dermatolymphanioadenitis (DLA) in course of ‘filarial’ lymphedema. Acta Trop 73 217-224.
50. G Dreyer, D Addiss, P Gadelha, et al. (2006) Interdigital skin lesions of the lower limbs among patients with lymphoedema in an area endemic for bancroftian filariasis. Trop Med Int Hlth 11 1475-1481.
51. J Norões, D Addiss, A Cedenho, et al. (2003) Pathogenesis of filarial hydrocele: risk associated with intrascrotal nodules caused by death of adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 97 561-566.
52. E Michael, PE Simonsen, M Malecela, et al. (2001) Transmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa. Parasite Immunol 23 373-388.
53. WA Stolk, KD Ramaiah, GJ van Oortmarssen, et al. (2004) Meta-analysis of age-prevalence patterns in lymphatic filariasis: no decline in microfilaraemia prevalence in older age groups as predicted by models with acquired immunity. Parasitology 129 605-612.
54. W Melrose, J Usurup, B Selve, et al. (2000) Development of anti-filarial antibodies in a group of expatriate mine-site workers with varying exposure to the disease. Trans R Soc Trop Med Hyg 94 706-707.
55. NO Nielsen, PE Simonsen, P Magnussen, et al. (2006) Cross-sectional relationship between HIV, lymphatic filariasis and other parasitic infections in adults in coastal northeastern Tanzania. Trans R Soc Trop Med Hyg 100 543-550.
56. DG Addiss and G Dreyer (2000) Treatment of lymphatic filariasis. TB Nutman (Ed.) Lymphatic Filariasis London: Imperial College Press 151-199.
57. MJ Taylor, WH Makunde, HF McGarry, et al. (2005) Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomized placebo-controlled trial. Lancet 365 2116-2121.
58. AY Debrah, S Mand, S Specht, et al. (2006) Doxycycline reduce plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2 829-843.
59. O Hussein, M El Setouhy, ES Ahmed, et al. (2004) Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in bancroftian filariasis. Am J Trop Med Hyg 71 471-477.
60. DO Freedman, T Bui, PJA Filho, et al. (1995) Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. Am J Trop Med Hyg 52 258-261.
61. PE Simonsen, SM Magesa, DW Meyrowitsch, et al. (2005) The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenemia. Trans R Soc Trop Med Hyg 99 541-547.
62. G Dreyer, ML Pires, LD Andrade, et al. (1994) Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of bancroftian filariasis, Recife, Brazil. Trans R Soc Trop Med Hyg 88 232-236.
63. W Cao, CPB Ploeg, AP Plaisier, et al. (1997) Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Trop Med Int Hlth 2 393-403.
64. RK Shenoy, V Kumaraswami, TK Suma, et al. (1999) A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasitol 93 367-377.
65. AS Kerketta, BV Babu, K Rath, et al. (2005) A randomized clinical trial to compare the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lymphoedema. Trop Med Int Hlth 10 698-705.
66. DW Meyrowitsch, PE Simonsen and SM Magesa (2004) A 26-year follow-up of bancroftian filariasis in two communities in north-eastern Tanzania. Ann Trop Med Parasitol 98 155-169.
67. NDE Alexander and BT Grenfell (1999) The effect of pregnancy on Wuchereria bancrofti microfilarial load in humans. Parasitology 119 151-156.
68. PJ Lammie, WL Hitch, EMW Allen, et al. (1991) Maternal filarial infection as risk factor for infection in children. Lancet 337 1005-1006.
69. PK Das, A Sirvidya, P Vanamail, et al. (1997) Wuchereria bancrofti microfilaraemia in children in relation to parental infection status. Trans R Soc Trop Med Hyg 91 677-679.
70. RT Rwegoshora, EM Pedersen, DA Mukoko, et al. (2005) Bancroftian filariasis: patterns of vector abundance and transmission in two East African communities with different levels of endemicity. Ann Trop Med Parasitol 99 253-265.
71. RT Rwegoshora, PE Simonsen, DW Meyrowitsch, et al. (2007) Bancroftian filariasis: house-to-house variation in the vectors and transmission - and the relationship to human infection - in an endemic community of coastal Tanzania. Ann Trop Med Parasitol 101 51-60.
72. World Health Organization (2002) Defining the roles of vector control and xenomonitoring in the Global programme to Eliminate Lymphatic Filariasis Geneva: WHO WHO/CDS/CPE/PVC/2002.3.
73. G Dreyer, J Norões and D Addiss (1997) The silent burden of sexual disability associated with lymphatic filariasis. Acta Trop 63 57-60.
74. CK Ahorlu, SK Dunyo, G Asamoah, et al. (2001) Consequences of hydrocele and the benefits of hydrocelectomy: a qualitative study in lymphatic filariasis endemic communities on the coast of Ghana. Acta Trop 80 215-221.
75. EA Ottesen, BOL Duke, M Karam, et al. (1997) Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75 491-503.
76. E Mathieu, PJ Lammie, J Radday, et al. (2004) Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti. Ann Trop Med Parasitol 98 703-714.
77. A Krentel, P Fischer, P Manoempil, et al. (2006) Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia. Trop Med Int Hlth 11 1731-1740.
78. JO Gyapong, D Kyelem, I Kleinschmidt, et al. (2002) The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol 96 695-705.
79. AW Onapa, PE Simonsen, I Baehr, et al. (2005) Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens. Ann Trop Med Parasitol 99 141-153.
80. E Michael, MN Malecela-Lazari, PE Simonsen, et al. (2004) Mathematical modelling and the control of lymphatic filariasis. Lancet Inf Dis 4 223-234.
81. W Stolk, SJ de Vlas and JDF Habbema (2006) Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling. Filaria J 5 5.
82. DW Meyrowitsch and PE Simonsen (1998) Long-term effect of mass diethylcarbamazine chemotherapy on bancroftian filariasis: results at four years after start of treatment. Trans R Soc Trop Med Hyg 92 98-103.
83. J Critchley, D Addiss, H Ejere, et al. (2005) Albendazole for the control and elimination of lymphatic filariasis: systematic review. Trop Med Int Hlth 10 818-825.
84. G Dreyer, D Addiss, J Williamson, et al. (2006) Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 100 1118-1125.
85. EM Pedersen and DA Mukoko (2002) Impact of insecticide-treated materials on filaria transmission by the various species of vector mosquito in Africa. Ann Trop Med Parasitol 96 S91-S95.
86. EA Ottesen (2006) Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 61 395-441.
87. J O'Neill (1875) On the presence of a filaria in ‘craw-craw’. Lancet i 265-266.
88. R Robles (1917) Enfermedad nueva en Guatemala. Juventud Med 17 97-115.
89. DB Blacklock (1926) The development of Onchocerca volvulus in Simulium damnosum. Ann Trop Med Parasitol 20 1-48.
90. World Health Organization (1995) Onchocerciasis and its control. Report of a WHO expert committee on onchocerciasis control. WHO Tech Rep Ser 852.
91. BA Boatin and FO Richards (2006) Control of onchocerciasis. Adv Parasitol 61 349-394.
92. ME Murdoch, MC Asuzu, M Hagan, et al. (2002) Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol 96 283-296.
93. ME Murdoch, RJ Hay, CD Mackenzie, et al. (1993) A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol 129 260-269.
94. A Abiose (1998) Onchocercal eye disease and the impact of Mectizan treatment. Ann Trop Med Parasitol 92(suppl 1), S11-S22.
95. B Marin, M Boussinesq, M Druet-Cabanac, et al. (2006) Onchocerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol 22 17-20.
96. W Kipp, G Burnham, J Bamuhiiga, et al. (1996) The Nakalanga syndrome in Kabarole District, western Uganda. Am J Trop Med Hyg 54 80-83.
97. OO Kale (1998) Onchocerciasis: the burden of disease. Ann Trop Med Parasitol 92 S101-S115.
98. J Anderson, H Fuglsang, PJS Hamilton, et al. (1974) Studies on onchocerciasis in The United Cameroon Republic. II. Comparison of onchocerciasis in rain-forest and Sudan-savanna. Trans R Soc Trop Med Hyg 68 209-222.
99. JE McMahon, SC Sowa I, GH Maude, et al. (1988) Epidemiological studies of onchocerciasis in forest villages of Sierra Leone. Trop Med Parasitol 39 251-259.
100. S Mand, Y Marfo-Debrekyei, A Debrah, et al. (2005) Frequent detection of worm movements in onchocercal nodules by ultrasonography. Filaria J 4 1.
101. G Ozoh, M Boussinesq, AZ Bissek, et al. (2007) Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop Med Int Hlth 12 123-129.
102. JE Bradley and TR Unnasch (1996) Molecular approaches to the diagnosis of onchocerciasis. Adv Parasitol 37 57-106.
103. MA Rodrìguez-Pérez, A Domìnguez-Vázquez, J Méndez-Galvá, et al. (2003) Antibody detection tests for Onchocerca volvulus: comparison of the sensitivity of a cocktail of recombinant antigens used in the indirect enzyme-linked immunosorbent assay with a rapid-format antibody card test. Trans R Soc Trop Med Hyg 97 539-541.
104. EM Lipner, N Dembele, S Souleymane, et al. (2006) Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis 194 216-221.
105. LS Ayong, CB Tume, FE Wembe, et al. (2005) Development and evaluation of an antigen detection dipstick assay for the diagnosis of human onchocerciasis. Trop Med Int Hlth 10 228-233.
106. I Gillette-Ferguson, AG Hise, Y Sun, et al. (2006) Wolbachia- and Onchocerca volvulus-induced keratitis (river blindness) is dependent on myeloid differentiation factor 88. Infect Immun 74 2442-2445.
107. E Pearlman (1997) Immunopathology of onchocerciasis: a role for eosinophils in onchocercal dermatitis and keratitis. Chem Immunol 66 26-40.
108. EA Ottesen (1995) Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis 171 659-671.
109. BM Greene, HR Taylor and M Aikawa (1981) Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction. J Immunol 127 1611-1618.
110. T Garate, FJ Conraths, W Harnett, et al. (1996) Identification of Onchocerca volvulus collagen as an antigen mainly recognized by antibodies in chronic hyperactive onchodermatitis (Sowda). Am J Trop Med Hyg 54 490-497.
111. A Van der Lelij, A Rothova, JS Stilma, et al. (1990) Humoral and cell-mediated immune response against retinal antigens in relation to onchocerciasis. Acta Leiden 59 271-283.
112. PT Soboslay, SM Geiger, B Drabner, et al. (1999) Prenatal immune priming in onchocerciasis- Onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers. Clin Exp Immunol 117 130-137.
113. JS McCarthy, EA Ottesen and TB Nutman (1994) Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J Infect Dis 170 736-741.
114. GR Stewart, M Boussinesq, T Coulson, et al. (1999) Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol 117 517-523.
115. PJ Cooper, I Espinel, M Wieseman, et al. (1999) Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus response. Infect Immunol 67 5951-5957.
116. SA Tawill, M Gallin, Erttmann, et al. (1996) Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients. Trans R Soc Trop Med Hyg 90 85-89.
117. AY Debrah, S Mand, Y Marfo-Debrekyei, et al. (2006) Assessment of microfilarial loads in the skin of onchocerciasis patients with different regimens of doxycycline regimens plus ivermectin. Filaria J 5 1.
118. K Awadzi, KY Dadzie, S Klager, et al. (1989) The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control. Trop Med Parasitol 40 361-366.
119. JA Whitworth, D Morgan, GH Maude, et al. (1988) Community-based treatment with ivermectin. Lancet ii 97-98.
120. J Gardon, M Boussinesq, J Kamgno, et al. (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomized controlled trial. Lancet 360 203-210.
121. D Mabey, JA Whitworth, M Eckstein, et al. (1996) The effects of multiple doses of ivermectin on ocular onchocerciasis. Ophthalmology 103 1001-1008.
122. JE McMahon, JB Davies, MD White, et al. (1986) Onchocerciasis in Sierra Leone I. Studies on the prevalence and transmission at Gbaiima village. Trans R Soc Trop Med Hyg 80 802-809.
123. JDF Habbema, ES Alley, AP Plaisier, et al. (1992) Epidemiological modelling for onchocerciasis control. Parasitol Today 8 99-103.
124. M-G Basáñez and M Boussinesq (1999) Population biology of human onchocerciasis. Philos Trans R Soc Lond [Biol] 354 809-826.
125. L Toé, J Tang, C Back, et al. (1997) Vector-parasite transmission complexes for onchocerciasis in West Africa. Lancet 349 163-166.
126. PA Zimmerman, KY Dadzie, G DeSole, et al. (1992) Onchocerca volvulus DNA probe classification correlated with epidemiological patterns of blindness. J Infect Dis 165 964-968.
127. TB Higazi, A Filiano, CR Katholi, et al. (2005) Wolbachia endosymbiont levels in severe and mild strains of Onchocerca volvulus. Mol Biochem Parasitol 141 109-112.
128. EM Pedersen and BT Maegga (1985) Quantitative studies on the transmission of Onchocerca volvulus by Simulium damnosum s.l. in the Tukuyu Valley, south west Tanzania. Tropenmed Parasitol 36 249-254.
129. WH Makunde, FM Salum, JJ Massaga, et al. (2000) Clinical and parasitological aspects of itching caused by onchocerciasis in Morogoro, Tanzania. Ann Trop Med Parasitol 94 793-799.
130. PA Zimmerman, CR Katholi, MC Wooten, et al. (1994) Recent evolutionary history of American Onchocerca volvulus, based on analysis of a tandemly repeated DNA sequence family. Mol Biol Evol 11 384-392.
131. C Botto, AJ Gillespie, S Vivas-Martinez, et al. (1999) Onchocerciasis hyperendemic in the Unturán Mountains: the value of recombinant antigens in describing a new transmission area in southern Venezuela. Trans R Soc Trop Med Hyg 93 25-30.
132. A Corredor, RS Nicholls, S Duque, et al. (1998) Current status of onchocerciasis in Columbia. Am J Trop Med Hyg 58 594-598.
133. RH Guderian and AJ Shelley (1992) Onchocerciasis in Ecuador: the situation in 1989. Mem Inst Oswaldo Cruz 87 405-415.
134. TG Evans (1995) Socioeconomic consequences of blinding onchocerciasis in West Africa. Bull World Health Organ 73 495-506.
135. C Vlassoff, M Weiss, EBL Ovuga, et al. (2000) Gender and the stigma of onchocercal skin disease in Africa. Soc Sci Med 50 1353-1368.
136. B Boatin, DH Molyneux, JM Hougard, et al. (1997) Patterns of epidemiology and control of onchocerciasis in West Africa. J Helminthol 71 91-101.
137. J-M Hougard, L Yaméogo, A Sékétéli, et al. (1997) Twenty-two years of blackfly control in the Onchocerciasis Control Programme in West Africa. Parasitol Today 13 425-431.
138. G De Sole, K Awadzi, J Remme, et al. (1989) A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions. Trop Med Parasitol 40 375-382.
139. BA Boatin, J-M Hougard, ES Alley, et al. (1998) The impact of Mectizan on the transmission of onchocerciasis. Ann Trop Med Parasitol 92 S47-S60.
140. MM Alleman, NAY Twum-Danso and BI Thylefors (2006) The Mectizan® Donation Program - highlights from 2005. Filaria J 5 11.
141. WR Brieger, AK Awedoba, CI Eneanya, et al. (1998) The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Trop Med Int Hlth 3 951-961.
142. J Gardon, N Gardon-Wendel, Demanga-Ngangue, et al. (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350 18-22.
143. K Awadzi, DA Boakye, G Edwards, et al. (2004) An investigation of persistent microfilaridermia despite multiple treatments with ivermectin in two onchocerciasis endemic foci in Ghana. Ann Trop Med Parasitol 98 231-249.
144. AD Hopkins (2005) Ivermectin and onchocerciasis: is it all solved? Eye 19 1057-1066.
145. M Boussinesq (2006) Loiasis. Ann Trop Med Parasitol 100 715-731.
146. F Noireau, JD Apembet, A Nzoulani, et al. (1990) Clinical manifestations of loiasis in an endemic area in the Congo. Trop Med Parasitol 41 37-39.
147. AD Klion, M Massougbodji, B-C Sadeler, et al. (1991) Loiasis in endemic and non-endemic populations: immunologically mediated differences in clinical presentation. J Infect Dis 163 1318-1325.
148. JJ Andy, FF Bishara and OO Soyinka (1981) Relation of severe eosinophilia and microfilariasis to chronic African endomyocardial fibrosis. Br Heart J 45 672-680.
149. T Lukiana, M Mandina, NH Situakibanza, et al. (2006) A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy. Filaria J 5 6.
150. TC Orihel and ML Eberhard (1998) Zoonotic filariasis. Clin Microbiol Rev 11 366-381.
151. DR Churchill, C Morris, A Kakoya, et al. (1996) Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the UK. J Infect 33 103-109.
152. A Dupont, J Zue-N'dong and M Pinder (1988) Common occurrence of amicrofilaraemic Loa loa filariasis within the endemic region. Trans R Soc Trop Med Hyg 82 730.
153. AD Klion, A Vijaykumar, T Oei, et al. (2003) Serum immunoglobulin G4 antibodies to the recombinant antigen, Ll-SXP-1, are highly specific for Loa loa infection. J Infect Dis 187 128-133.
154. FS Touré, E Mavoungou, L Kassambara, et al. (1998) Human occult loiasis: field evaluation of a nested polymerase chain reaction assay for the detection of occult infection. Trop Med Int Hlth 3 505-511.
155. M Pinder, A Dupont and TG Egwang (1988) Identification of a surface antigen on Loa loa microfilariae the recognition of which correlates with the amicrofilaraemic state in man. J Immunol 141 2480-2486.
156. S Baize, G Wahl, PT Soboslay, et al. (1997) T helper responsiveness in human Loa loa infection; defective specific proliferation and cytokine production by CD4+ T cells from microfilaraemic subjects compared with amicrofilaraemics. Clin Exp Immunol 108 272-278.
157. AD Klion, EA Ottesen and TB Nutman (1994) Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis 169 604-610.
158. TH Duong, M Kombila, A Ferrer, et al. (1997) Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin. Trans R Soc Trop Med Hyg 91 592-593.
159. MV Hoegaerden, B Ivanoff, F Flocard, et al. (1987) The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol 81 275-282.
160. T-E Tabi, R Befidi-Mengue, TB Nutman, et al. (2004) Human loiasis in a Cameroonian village: A double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen. Am J Trop Med Hyg 71 211-215.
161. AD Klion, J Horton and TB Nutman (1999) Albendazole therapy for loiasis refractory to diethylcarbamazine treatment. Clin Infect Dis 29 680-682.
162. S Wanji, N Tendongfor, M Esum, et al. (2003) Heterogeneity in the prevalence and intensity of loiasis in five contrasting bioecological zones in Cameroon. Trans R Soc Trop Med Hyg 97 182-187.
163. TB Nutman, KD Miller, M Mulligan, et al. (1988) Diethylcarbamazine provides effective prophylaxis for human loiasis. N Engl J Med 319 752-756.
164. CA Fux, B Chappuis, B Holzer, et al. (2006) Mansonella perstans causing symptomatic hypereosinophilia in a missionary family. Travel Med Infect Dis 4 275-280.
165. ER Bregani, A Rovellini, M Mbaïdoum, et al. (2006) Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis. Trans R Soc Trop Med Hyg 100 458-463.
166. TH Duong, M Kombila, A Ferrer, et al. (1998) Decrease in Mansonella perstans microfilaraemia after albendazole treatment. Trans R Soc Trop Med Hyg 92 459.
167. P Fischer, AHD Kilian, J Bamuhiiga, et al. (1996) Prevalence of Mansonella perstans in western Uganda and its detection using the QBC-fluorescence method. Appl Parasitol 37 32-37.
168. AW Onapa, PE Simonsen, I Baehr, et al. (2005) Rapid assessment of the geographical distribution of Mansonella perstans infections in Uganda, by screening schoolchildren for microfilariae. Ann Trop Med Parasitol 99 383-393.
169. P Fischer, J Bamuhiiga and DW Büttner (1997) Occurrence and diagnosis of Mansonella streptocerca in Uganda. Acta Trop 63 43-55.
170. P Fischer, DW Büttner, J Bamuhiiga, et al. (1998) Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay. Am J Trop Med Hyg 58 816-820.
171. P Fischer, E Tukesiga and DW Büttner (1999) Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin. J Infect Dis 180 1403-1405.
172. A Bartoloni, G Cancrini, F Bartalesi, et al. (1999) Mansonella ozzardi infection in Bolivia: prevalence and clinical association in the Chaco Region. Am J Trop Med Hyg 61 830-833.
173. DF McNeeley, CP Raccurt, J Boncy, et al. (1988) Clinical evaluation of Mansonella ozzardi in Haiti. Trop Med Parasitol 40 107-110.
174. RJ Post, Z Adams, AJ Shelley, et al. (2003) The morphological discrimination of microfilariae of Onchocerca volvulus from Mansonella ozzardi. Parasitology 127 21-27.
175. AA González, DD Chadee and SC Rawlins (1998) Single dose of ivermectin to control mansonellosis in Trinidad: a four-year follow-up study. Trans R Soc Trop Med Hyg 92 570-571.
176. F Simón, J López-Belmonte, C Marcos-Atxutegi, et al. (2005) What is happening outside North America regarding human dirofilariasis. Vet Parasitol 133 181-189.
177. JH Theis (2005) Public health aspects of dirofilariasis in the United States. Vet Parasitol 133 157-180.
178. S Pampiglione, GC Trotti and F Rivasi (1995) Human dirofilariasis due to Dirofilaria (Nochtiella) repens: a review of world literature. Parassitologia 37 149-193.
179. L Yelifari, E Frempong and A Olsen (1997) The intermediate hosts of Dracunculus medinensis in Northern Region, Ghana. Ann Trop Med Parasitol 91 403-409.
180. P Bloch and PE Simonsen (1998) Immunoepidemiology of Dracunculus medinensis infections. I. Antibody responses in relation to infection status. Am J Trop Med Hyg 59 978-984.
181. P Bloch and PE Simonsen (1998) Immunoepidemiology of Dracunculus medinensis infections. II. Variation in antibody responses in relation to transmission season and patency. Am J Trop Med Hyg 59 985-990.
182. JE Rohde, BL Sharma, H Patton, et al. (1993) Surgical extraction of guinea worm: disability reduction and contribution to disease control. Am J Trop Med Hyg 48 71-76.
183. A Issaka-Tinorgah, P Magnussen, P Bloch, et al. (1994) Lack of effect of ivermectin on prepatent guinea-worm: a single-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg 88 346-348.
184. L Bimi, AR Freeman, ML Eberhard, et al. (2005) Differentiating Dracunculus medinensis from D. insignis, by the sequence analysis of the rRNA gene. Ann Trop Med Parasitol 99 511-517.
185. E Ruiz-Tiben and DR Hopkins (2006) Dracunculiasis (Guinea worm disease) eradication. Adv Parasitol 61 275-309.
186. JM Hunter (1997) Bore holes and the vanishing of guinea worm disease in Ghana's Upper Region. Soc Sci Med 45 71-89.
187. A Olsen, P Magnussen and S Anemana (1997) The acceptability and effectiveness of a polyester drinking-water filter in a dracunculiasis-endemic village in Northern Region, Ghana. Bull World Health Organ 75 449-452.